Get the Stockscreener App
4.61
4.75%
-0.23
After Hours:
4.50
-0.11
-2.39%
Envveno Medical Corporation stock is traded at $4.61, with a volume of 159.08K.
It is down -4.75% in the last 24 hours and up +15.54% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$4.84
Open:
$4.94
24h Volume:
159.08K
Relative Volume:
1.36
Market Cap:
$80.84M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-2.1442
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-8.17%
1M Performance:
+15.54%
6M Performance:
+40.12%
1Y Performance:
-14.31%
1-Day Range:
$4.61
$5.0685
1-Week Range:
$4.61
$5.27
52-Week Range:
$2.0278
$5.81
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
4.61 | 84.87M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Envveno Medical Corporation Stock (NVNO) Latest News
What makes enVVeno Medical Corporation stock price move sharplyTrading Volume Anomaly Summary and Insight - Newser
Key metrics from enVVeno Medical Corporation’s quarterly dataReversal Signal Prediction Based on Volume - Newser
enVVeno Medical Posts Continued Losses in Q2 2025; Earnings Fail to Drive Market Optimism - AInvest
Is enVVeno Medical Corporation stock overvalued or undervaluedChart Pattern Growth Plan For Smart Trading - jammulinksnews.com
Using flow based indicators on enVVeno Medical CorporationFree Watchlist for Low Risk High Return - Newser
Is now a turning point for enVVeno Medical CorporationSafe and Scalable Return Strategy Blueprint - Newser
Why enVVeno Medical Corporation stock attracts strong analyst attentionBuy Strategy with Smart Exit Timing - Newser
How many analysts rate enVVeno Medical Corporation as a “Buy”Top Growth Strategy From AI Tools - jammulinksnews.com
enVVeno Medical Corporation Stock Support and Resistance Levels You Should KnowShort Term Setup With Predictive Chart Confirmed - metal.it
Risk adjusted return profile for enVVeno Medical Corporation analyzedReal-Time Signal Tracking with Entry Level - Newser
What Technical Tools Say About enVVeno Medical Corporation Recovery - metal.it
Reversal Confirmed enVVeno Medical Corporation Stock Rallies Above MAAI Powered High Return Stock Calls Dominate Watchlists - metal.it
What is the dividend policy of enVVeno Medical Corporation stockSwing Trade Outlook For Every Investor - jammulinksnews.com
What institutional investors are buying enVVeno Medical Corporation stockFree Trend-Following Techniques - jammulinksnews.com
When is enVVeno Medical Corporation stock expected to show significant growthAchieve breakthrough gains with expert advice - jammulinksnews.com
Is enVVeno Medical Corporation a growth stock or a value stockMaximize gains with strategic stock entries - jammulinksnews.com
What are analysts’ price targets for enVVeno Medical Corporation in the next 12 monthsInvest smarter with actionable trading signals - jammulinksnews.com
enVVeno Medical (NVNO) to Release Earnings on Wednesday - Defense World
enVVeno Medical NVNO 2025Q2 Earnings Preview Upside Anticipated on Revenue Surge and EPS Growth - AInvest
What are the technical indicators suggesting about enVVeno Medical CorporationMarket-leading growth rates - jammulinksnews.com
How does enVVeno Medical Corporation generate profit in a changing economyRemarkably fast returns - jammulinksnews.com
What are enVVeno Medical Corporation company’s key revenue driversPhenomenal returns - jammulinksnews.com
Is it the right time to buy enVVeno Medical Corporation stockTrack top-performing stocks effortlessly - jammulinksnews.com
Is enVVeno Medical Corporation Stock a Smart Buy in 2025 Investment Analysis InsideShort Term Risk Controlled Alerts - metal.it
How strong is enVVeno Medical Corporation company’s balance sheetUnlock powerful trading tools for investors - jammulinksnews.com
How Resilient Is enVVeno Medical Corporation Stock During Economic DownturnsFree Best Performing Stock Suggestions - metal.it
How enVVeno Medical Corporation stock performs during market volatilityMinimized Risk Trading Plan - Newser
Is enVVeno Medical Corporation a good long term investmentExtraordinary performance - PrintWeekIndia
enVVeno Medical Corporation Stock Analysis and ForecastConsistently high yield - Autocar Professional
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Lohud
What drives enVVeno Medical Corporation stock pricePhenomenal returns - jammulinksnews.com
What analysts say about enVVeno Medical Corporation stockExplosive wealth accumulation - Autocar Professional
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):